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Summary
Alx3 is a Paired-class aristaless-like homeoprotein expressed during embryonic
development. Transcriptional transactivation by aristaless-like proteins has been
associated to cooperative dimerization upon binding to artificially generated DNA
consensus sequences known as P3-sites, but natural target sites in genes regulated by
Alx3 are unknown. We report the cloning of a cDNA encoding the rat homolog of
Alx3, and characterize the protein domains that are important for transactivation,
dimerization, and binding to DNA. Two proline-rich domains located amino-terminal
to the homeodomain (Pro1 and Pro2) are necessary for Alx3-dependent
transactivation, whereas another one (Pro3) located in the carboxi-terminal is
dispensable but contributes to enhance the magnitude of the response. We confirmed
that transcriptional activity of Alx3 from a P3-site correlates with cooperative
dimerization upon binding to DNA. However, Alx3 was found to selectively bind to
non-P3-related TAAT-containing sites present in the promoter of the somatostatin
gene in a specific manner that depends on the nuclear protein environment. Cell-
specific transactivation elicited by Alx3 from these sites could not be predicted from
in vitro DNA-binding experiments using recombinant Alx3. In addition,
transactivation did not depend on cooperative dimerization upon binding to cognate
somatostatin DNA sites. Our data indicate that the paradigm according to which Alx3
must act homodimerically via cooperative binding to P3-like sites is insufficient to
explain the mechanism of action of this homeoprotein to regulate transcription of
natural target genes. Instead, Alx3 undergoes restrictive or permissive interactions
with nuclear proteins that determine its binding to and transactivation from TAAT
target sites selected in a cell-specific manner.
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Introduction
Homeodomain proteins are a large family of transcription factors that play
prominent roles during embryonic development (1,2). These proteins are characterized
by the existence of a common DNA-binding structure, known as the homeodomain,
that contains three α-helices spanning 60 amino acids. Comparison of amino acid
sequences of known homeodomains from different species shows that residues in the
first and third helices are highly conserved. Thus, the relative degree of sequence
similarity in the DNA-binding domain defines different classes of homeodomain
proteins which relate to protein homologs encoded by Drosophila melanogaster genes
(3).
Among the different classes of homeoproteins categorized so far, an important
group with major roles in embryonic development is that of Paired-class proteins,
characterized by the presence of a homeodomain homologous to the one encoded by
the Drosophila paired gene (4). Additional conserved regions located outside the
homeodomain define different subsets of Paired-class transcription factors.
One of these subsets of Paired-class homeoproteins is characterized by the
presence of a conserved domain located in the C-terminal region known as OAR or
aristaless domain (4,5). Some of the homeoproteins within this subset are encoded by
the so called group-I aristaless-related genes. This group includes the Prx-domain-
containing proteins Prx1 and Prx2 (6), as well as the homeoproteins Alx3 (7,8), Alx4
(9), and Cart1 (10) which are highly related both structurally and functionally (5).
Aristaless-related genes exhibit overlapping patterns of expression during
development in tissues that include the cranial mesenchyme derived from the neural
crest, branchial arches, body wall mesoderm and limb buds (11).
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Some of the functions of the genes encoding aristaless-like transcription factors
have been studied in mice carrying mutant alleles. These studies revealed that group-I
aristaless-related genes are required for correct skeletal development, since the
presence of loss-of-function mutations leads to defects in craniofacial and limb
morphogenesis. Specifically, targeted inactivation of Cart1 causes defects in the
formation of craniofacial skeleton and in the closure of the neural tube, leading to
acrania and meroanencephaly (12), and Alx4 mutant mice exhibit cranial bone
defects, polydactyly and body wall defects (13-15). Alx3 mutant mice have been
generated by targeted homologous recombination, but phenotypic defects in these
animals have not been reported (16). This finding suggests that there is functional
redundancy among these genes, a notion further supported by studies carried out in
Alx3/Alx4 and Alx4/Cart1 double mutant mice, which show the existence of
overlapping functions of these genes during embryonic development (16,17).
Despite recent advances in our understanding of the developmental functions of
transcription factors encoded by aristaless-related genes, little is known about their
mechanism of action at the transcriptional level and the target genes that they regulate.
In the present study, we report the cloning of a cDNA encoding the rat homolog of
Alx3, and an initial molecular characterization of this transcription factor. We identify
novel DNA sites from which Alx3 can activate transcription, and we show that a
region spanning the homeodomain and adjacent residues is sufficient for protein
dimerization and selective sequence-specific DNA binding, whereas full
transcriptional activity requires the integrity of proline-rich domains located at either
side of the homeodomain.
Functional characterization of Alx3
5
Experimental Procedures
Cell lines.–Neural RC2.E10 and RH1.C4 cells derive from cortex and hippocampus,
respectively, of rat fetuses of 16 days of gestational age, and were cultured at a
temperature of 33 ºC as described (18,19). Hela cells, BHK-21 cells (baby hamster
kidney fibroblasts) (ATCC CCL10) and rat pancreatic islet somatostatin-producing
RIN-1027-B2 cells (20) were cultured at a temperature of 37 ºC in DMEM containing
10% fetal bovine serum in the presence of penicillin (100 U/ml) and streptomycin (10
µg/ml). RIN-1027-B2 and RC2.E10 cells were transfected using Lipofectin (Life
Technologies, Inc.) as described (18). Hela and BHK-21 cells were transfected using the
calcium phosphate precipitation method.
RT-PCR with degenerate oligonucleotides.–Total RNA (5 µg) purified by CsCl gradient
centrifugation from RC2.E10 or RH1.C4 cells was primed with poly-(dT)15 (100 ng)
and incubated with avian myeloblastosis virus reverse transcriptase (Boehringer
Mannheim Biochemicals, Indianapolis, IN) in a total volume of 30 µl to synthesize
cDNA. Four µl of this cDNA preparation were used as template for PCR amplification,
using degenerate oligonucleotides corresponding to the conserved residues QLDVLE
and QVWFKN found in helices 1 and 3, respectively, of orthodenticle-like
homeodomains. The sequences of these oligonucleotides are as follows: Sense, 5’-
A C G A A T T C C A ( A / G ) C T I G A ( C / T ) G T I C T I G A - 3 ’ ;  a n t i s e n s e  5 ’ -
ACGGATCC(A/G)TT(T/C)TT(G/A)AACCAIAC(T/C)TG-3’. A control sample that
lacked RNA was processed in parallel. PCR conditions for amplifications were 95 ºC
for 2 minutes, followed by 30 cycles of 94 ºC for 30 seconds, 40 ºC for 30 seconds, and
72 ºC for 30 seconds, after which a 5 minute incubation at 72 ºC followed. The expected
size of the PCR products was 120 bp.
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The degenerate oligonucleotide amplimers used contain BamHI or EcoRI
restriction enzyme sites added to their 5’ ends to allow directional cloning of the
resulting PCR products in pBluescript-KS(-). After this was done, E. coli JM109 were
transformed, and plasmid DNA prepared from several individual bacterial colonies were
sequenced using the dideoxy chain termination method (Sequenase kit, United States
Biochemicals, Cleveland, OH). Sequences were compared with GenBank entries using
the BLAST (Basic Local Alignment Search Protocol) network service on line provided
by the National Center for Biotechnology Information.
Isolation of full length rat Alx3 cDNA using 5’- and 3’-RACE.–To isolate the 3’ portion
of the cDNA encoding rat Alx3, a 3’-RACE system for rapid amplification of cDNA
ends (Gibco BRL) was used following basically the instructions provided by the
manufacturer. Total RNA was prepared from RC2.E10 or RH1.C4 cell lines as
indicated above. For cDNA template synthesis, we used poly-(dT)16 adapter primers
designed according to the sequence provided by the manufacturer, but with the
modification that the last two positions of the 3’-end were degenerate so that the
oligonucleotides would anchor to the 5’-end of the poly-A tails of the target mRNA.
Following reverse transcription, PCR was carried out using a reverse Universal
Amplification Primer (Gibco BRL) and a specific sense oligonucleotide that anneals to
the region encoding the rat Alx3 homeodomain. The sequence of this primer is 5’-
(CAU)4GAATTCAGAAAACCCTCTACCCT-3’, incorporating a CAU tail that allows
cloning of the PCR product into the plasmid pAMP-1 (Gibco BRL). PCR conditions
were 95 ºC for 2 minutes, followed by 30 cycles of 94 ºC for 30 seconds, 50 ºC for 30
seconds, and 72 ºC for 30 seconds, after which a 5 minute incubation at 72 ºC followed.
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The PCR products were inserted into pAMP-1 after treatment with uracil DNA
glycosylase (Gibco BRL), and sequenced after propagation into E. coli DH5α.
To isolate the 5’ portion of the rat Alx3 cDNA, 5’-RACE using a ligation-
anchored PCR-based procedure (21) was carried out. To this end, reverse transcription
of total RNA was performed using a specific reverse oligonucleotide that anneals to the
region encoding amino acids 314 to 319 located near the C-terminus of Alx3 (5’-
GTCGCCATCTGGAGAAGG-3’). The 3’ end of the resulting single-stranded cDNA
was ligated with T4 RNA ligase to an anchor oligonucleotide phosphorylated at its 5’-
end and blocked by a C3-amine group at the 3’-end (5’-
pGGTACCCTCGAGGAATTCAAGCTTG-C3amine-3’). Following this, PCR
amplification was carried out using a forward primer complementary to the anchor
oligonucleotide, and a reverse primer that anneals to the region encoding amino acids
180  t o  186  w i th in  t he  r a t  A lx3  homeodoma in  (5 ’ -
ACGGATCCAGCGCTCCCGAGCGTACACA-3’). This primer incorporates a BamHI
site at its 5’ end. PCR conditions were 95 ºC for 2 minutes, followed by 30 cycles of 94
ºC for 30 seconds, 55 ºC for 30 seconds, and 75 ºC for 30 seconds, after which a 5
minute incubation at 72 ºC followed. The PCR products were inserted into pBluescript-
KS(-) and sequenced after propagation into E. coli Stbl2 (Gibco BRL).
Northern blot.–Poly-A RNA was purified from total RNA prepared by CsCl
centrifugation, fractionated in 1% agarose formaldehyde gel electrophoresis and
transferred to a nylon membrane (Magnacharge, MSI, Westboro MA). For the synthesis
of the riboprobe, a 396 bp fragment corresponding to the 3’-untranslated region of the
rat Alx3 cDNA was generated by PCR using the following oligonucleotides: Forward,
5’-GAATTTAGGTGACACTATAGAAAGCGTGAGCGTTATGGGAAGA-3’;
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reverse, 5’-TGTAATACGACTCACTATAGGGTGAGACGAGGCTGGGGGACTT-
3’. These oligonucleotides incorporate SP6 and T7 polymerase recognition sites,
respectively. The PCR product was purified and the riboprobe was generated using a
Promega synthesis kit in the presence of 32P-CTP, following the instructions provided
by the manufacturer. Hybridization (42 ºC) and washes (65 ºC) were carried out
following standard protocols.
Plasmids.–The full-length Alx3 cDNA was assembled between the KpnI and BamHI
sites of pBluescript-KS(-) by ligating restriction fragments generated from the partial
cDNAs obtained as described above. A Muta-Gene phagemid kit (Bio-Rad) was used to
alter the coding sequence of the Alx3 cDNA by oligonucleotide-directed in vitro
mutagenesis so that the resulting cDNAs encode versions of Alx3 truncated at the
amino- or carboxy-terminals. To construct cDNAs encoding Alx3 amino-terminal
deletions the codon encoding the first methionine was converted into an NcoI restriction
site. NcoI restriction sites were also introduced by modifying codons encoding Leu57 or
Ser91. A naturally occurring NcoI site corresponding to the codon encoding Met143
was destroyed without altering the encoded residues. After generating these different
templates, the plasmids were digested with NcoI and religated after removal of the
insert. In this manner, cDNAs encoding the amino-terminal deletion mutants Alx357,
Alx391 and Alx3143 were generated. To generate the cDNAs encoding the carboxy-
terminal deletion mutants Alx31-228 and Alx31-279, the codons encoding Tyr228 (TAT) or
Gly279 (GGA) were mutated into the stop codons TAG or TGA, respectively. A cDNA
encoding Alx3143-228, which includes the Alx3 homeodomain (residues 153-212), was
generated by removing an NcoI fragment encoding amino acids 1-142 and introducing a
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stop codon in place of the codon encoding Tyr228. All the resulting cDNAs were
excised from pBluescript-KS(-) and inserted into the expression plasmid pcDNA3.
The luciferase reporter plasmids used in transient transfections were constructed
by ligating three tandem copies of the oligonucleotides P3 or P5 (22) into the BamHI
site of pT81Luc (23), which contains a minimal promoter from the herpes simplex virus
thymidine kinase gene. The chloramphenicol acetyltransferase (CAT)1 reporter plasmids
UEB-SMS65 (also known as SMS120), TAAT1-SMS65, and TAAT2-SMS65 have
been described previously (18).
For bacterial expression of a fusion protein composed of glutathione S-
transferase- (GST-) and the carboxy-terminus of rat Alx3 (residues 212-343, excluding
the homeodomain), the plasmid GST-Alx3ΔN140C was constructed. For this purpose,
the rat Alx3 cDNA was used as a template to amplify a fragment encoding the last 140
amino acids of the carboxy-terminal region by PCR. This region does not include
residues within the homeodomain. The sequence of the forward PCR primer is 5'-
ACGGATCCGAGCGTTATGGGAAGATA-3', and that of the reverse primer is 5'-
CAAAAGTGAGGCCAGACC-3'. The forward primer incorporates a BamHI site at its
5’ end. The reverse primer anneals to the 3’-untranslated region of the rAlx3 cDNA,
downstream from a unique HindIII restriction site. PCR conditions were: 95 °C for 5
min, followed by 30 cycles of 94 °C for 30 sec, 55 °C for 30 sec, and 72 °C for 30 sec,
after which a 5 min incubation at 72 °C followed. The PCR product was digested with
BamHI and HindIII and cloned into the plasmid pGEX-KG (24). A similar strategy was
used to generate GST-Alx3, a fusion protein including full length Alx3. In this case, the
s e q u e n c e  o f  t h e  f o r w a r d  P C R  p r i m e r  i s :  5 ’ -
ACGGATCCATGGAGCCCGAGCGCTGC-3’.
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To construct the plasmid encoding GST-Alx3143-228, a 473 bp fragment was cut
with NcoI from the cDNA encoding Alx31-228 in pBluescript-KS(-). This fragment was
cloned into the NcoI site of pGEX-KG.
Alx3 antiserum.–A polyclonal antiserum that recognizes the C-terminal region of rat
Alx3 (140 residues) was generated in a rabbit inoculated with the GST-Alx3ΔN140C
fusion protein expressed in E. coli JM109. Specificity of the antiserum was determined
by western immunoblot, using serum preabsorbed with GST or with GST-Alx3.
Western immunoblot.–Nuclear extracts (25) from cells growing in 60 mm dishes were
prepared and proteins were resolved by SDS-PAGE and blotted onto a nitrocellulose
membrane. Alx3 immunoreactivity was detected with a rabbit polyclonal primary
antiserum (1:5000 dilution), followed by incubation with a goat anti-rabbit peroxidase-
conjugated secondary antibody (1:10,000 dilution) (BioRad, Hercules, CA).
Immunoreactive bands were visualized using an enhanced chemiluminescence detection
system (ECL, Amersham, Buckinghamshire, England).
DNA-Protein binding assays.–Electrophoretic mobility shift assays (EMSA) were
carried out with full length or truncated versions of Alx3 generated by in vitro
translation using a rabbit reticulocyte lysate system (Promega) or with nuclear extracts
(25) of RC2.E10 cells in the presence of the protease inhibitors pepstatin A (1 mg/ml),
leupeptin (10 mg/ml), aprotinin (10 mg/ml) and p-aminobenzamidine (0.1 mM).
Synthetic complementary oligonucleotides with 5' GATC overhangs were annealed and
labeled by a fill-in reaction using α-32P-dATP and Klenow enzyme. Binding reactions
were carried out in the presence of 20,000 cpm of radiolabeled probe (approximately 6
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to 10 fmol) in a total volume of 20 µl containing 2 µg poly(dI.dC), 20 mM potassium
phosphate (pH 7.9),  70 mM KCl, 1 mM DTT, 0.3 mM EDTA, and 10% glycerol. The
sequences of the oligonucleotides used are as follows (coding strand):
P3, 5'-GATCCTGAGTCTAATTGAATTACTGTACA-3';
P5, 5'-GATCCTGAGTCTAATTGAGAATTACTGTA-3';
SMS-UE-B, 5'-GATCCGCGAGGCTAATGGTGCGTAA-3'
SMS-TAAT1, 5'-GATCCCTGATTGCATATTAATTCTCAGATA-3';
SMS-TAAT2, 5'-GATCCGATCTCAGTAATTAATCATGCACCA-3';
SMS-TAAT3, 5'-GATCCCAAGTCCAGTAATCTGAGTACATA-3';
GFAPT1, 5'-GATCCATAGACATAATGGTCAGGA-3';
GFAPT2, 5'-GATCCGAGAGTGTAATTTAGGCTA-3';
GFAPT3, 5'-GATCCTTTGCCAATTAGTGTGACA-3';
Chromatin immunoprecipitation (ChIP) assays.–ChIP assays were carried out basically
as descried by Gerrish et al. (26). Subconfluent cultures of RIN-1027-B2 cells were
treated with 1% formaldehyde for 10 minutes at room temperature and the cross-linked
protein-DNA complexes were isolated. Chromatin was sonicated and incubated with
anti-Alx3 antiserum or control normal rabbit serum. Antibody-protein-DNA complexes
were isolated by incubation with protein A-Sepharose. Bound DNA was detected by
PCR using oligonucleotide primers that amplify a fragment of the somatostatin gene
spanning nucleotides –550 to –120. PCR conditions were: 95 °C for 5 min, followed by
30 cycles of 94 °C for 30 sec, 55 °C for 30 sec, and 72 °C for 30 sec, after which a 5
min incubation at 72 °C followed. The sequence of the oligonucleotide primers are:
Forward,  5’-GATTGGACAAAGTGATGCTC-3’;  and reverse,  5’-
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AGTGAGGGGAGGCGACAC-3’. PCR products were run on a 1% agarose gel, stained
with ethidium bromide, and photographed.
GST pull-down assays.–Full length or truncated versions of [35S]-Met-labeled Alx3
were generated by in vitro translation using a rabbit reticulocyte lysate system
(Promega), and were incubated with recombinant GST-Alx3, GST-Alx3143-228, or its
deletion mutant control GST-Alx3ΔN140C expressed in bacteria and bound to
glutathione-Sepharose beads (Amersham Biosciences). Incubations were carried out at 4
ºC for 1 hour in buffer containing 20 mM sodium phosphate (pH 7.9), 150 mM KCl, 0.5
mM EDTA, 0.02 % Triton, 1 mM phenylmethylsulfonyl fluoride, and 2 µg/ml
aprotinin. After extensive washing, the bead-bound proteins were denatured, resolved
by SDS-PAGE, and detected by autoradiography.
Results
Isolation of rat Alx3 cDNA.–A degenerate RT-PCR-based screen initially aimed at
identifying orthodenticle-related homeodomain genes expressed in neural cell lines
yielded several homeodomain region-encoding clones whose translated sequence was
identical to that of mouse, human and hamster Alx3 (7,8,27). Clones encoding the
homeodomains of Otx1 and Otx2 were also identified but no additional Otx-related
genes were detected.
The full-length rat Alx3 cDNA2 isolated using 3’- and 5’-RACE is 1.8 kb in size.
However, a number of clones generated by 3’-RACE were found to contain a shorter 3’
untranslated region followed by a poly-A tail at nucleotide 1724, suggesting that at least
two different polyadenylation sites may be used. A putative RNA destabilization signal
(AUUUA) (28) was identified within the 3’ untranslated region. Northern blot analysis
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confirmed the presence of Alx3 mRNA of the expected size in the head and trunk of rat
E12 embryos (Fig. 1).
The cloned cDNA encodes a protein of 343 amino acids whose homeodomain is
located between residues 153 and 212. The sequence of the rat Alx3 homeodomain is
identical to that of the Alx3 homeodomain from human (27), hamster (7) and mouse (8).
Outside the homeodomain, rat Alx3 exhibits a high degree of amino acid identity with
the known Alx3 orthologs from other species (Fig. 2). These regions are characterized
by a relatively high proportion of proline residues distributed into three different
domains, two of them in the amino terminal region, named Pro1 and Pro2 and spanning
amino acids 3-79 (25% proline content) and 104-141 (23% proline content),
respectively; and one in the carboxy terminal region named Pro3 and spanning amino
acids 223-336 (19% proline content) (Fig. 2).
Characterization of transcriptionally active domains within Alx3.–To test the functional
activity of Alx3, we constructed reporter plasmids bearing three copies of P3 or P5
binding sites, which contain two inverted “TAAT” motifs separated by three or five
nucleotides, respectively (22). It is known that aristaless-like homeodomain proteins
bind preferentially to these sites as dimers (to P3) or monomers (to P5) (17,29).
Neural RC2.E10 cells were cotransfected with either 3xP3TK-Luc or 3xP5TK-
Luc reporters and pcDNA-Alx3, an expression vector encoding full length rat Alx3. We
found that Alx3 increased the luciferase activity elicited by 3xP3TK-Luc by 2-3 fold,
but did not increase the activity elicited by 3xP5TK-Luc, which was low and close to
background levels (data not shown).
To avoid interferences with endogenous Alx3 expressed in RC2.E10 cells, we
used BHK-21 cells, since they do not express Alx3 as shown by western immunoblot
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(see Fig. 6A). Figure 3A shows that cotransfection of the Alx3 expression vector in
BHK-21 fibroblasts results in higher luciferase activity elicited from the P3-bearing
reported plasmid, but not from the P5-bearing reporter plasmid.
To identify regions of Alx3 corresponding to functional domains required for
transactivation, we introduced sequential deletions in the amino terminus to residues 57,
91, or 143, without affecting the integrity of the homeodomain (Fig. 3B). We found that
deletion of residues 1-57 (Alx357) reduced 3xP3TK-Luc activity elicited by Alx3 to 60-
70% of that obtained with the full length protein, and that a further deletion to residue
91 (Alx391) reduced Alx3 transactivational activity to less than 50% (Fig. 3C). Deletion
of residues 1-143 (Alx3143), which eliminated the entire amino terminal region to a
position close to the homeodomain, resulted in levels of luciferase activity similar to
those obtained with cotransfection of control empty pcDNA3 vector. A similar lack of
activation was observed when we used Alx3143-228, a truncated Alx3 protein in which
both the amino and the carboxy terminal regions were deleted, leaving the
homeodomain intact (Fig. 3C). These experiments indicate that regions located in the
amino terminus are required for transactivation by Alx3.
However, further experiments demonstrated that regions located within the
carboxy terminal domain of Alx3 are important although not essential for full
transcripcional transactivation activity. Thus, a deletion of the last 64 residues (Alx31-
279) reduced 3xP3TK-Luc luciferase activity to 70% of that induced by full length Alx3,
whereas a deletion of the last 115 residues (Alx31-228), spanning almost entirely the Pro3
domain, reduced Alx3 transcriptional transactivation activity by 50% (Fig. 3C).
The homeodomain of Alx3 is sufficient for dimeric and monomeric binding to DNA.–To
investigate whether the deletion of the proline-rich domains affect binding to DNA, we
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carried out EMSA using 32P-labeled P3 and P5 oligonucleotide probes and truncated
versions of Alx3 generated in vitro with a reticulocyte lysate system. Figure 4A shows
that Alx3143 forms two complexes on the P3 probe, likely to correspond to monomeric
and dimeric forms, respectively. As predicted, only the monomeric form was observed
as the predominant complex bound to P5 (Fig. 4A). Similar results were obtained when
full length Alx3 was used (not shown). The dimeric nature of the upper complex bound
to P3, was confirmed by mixing Alx3143 with a lower molecular weight polypeptide
synthesized in vitro, corresponding to the Alx3 homeodomain extended by a few
residues at either side (Alx3143-228). In this case, an additional complex corresponding to
the Alx3143/Alx3143-228 dimer could be observed bound to P3 (Fig. 4B). These
experiments indicate that a relatively small region of Alx3 consisting of the
homeodomain and adjacent residues is sufficient for homodimerization and binding to
DNA.
Based on studies characterizing the binding of a generic paired-type
homeodomain to a P3 site (22,30), it has been predicted that dimerization of aristaless-
like homeodomains occurs cooperatively in a stepwise manner after binding of a
monomer to DNA (29). Although those studies have been taken as a paradigm for the
mechanism of dimerization of aristaless-like proteins, they do not rule out that
dimerization of these type of homeoproteins could take place also in the absence of a
cognate P3-like element. Indeed, it has been shown recently that Cart1 can dimerize in a
DNA-independent manner (31). To test whether Alx3 dimerization can take place in the
absence of a P3-like DNA binding site, we carried out GST-pull-down experiments. As
shown in figure 4C, [35S]-Met-labeled full length Alx3 is able to interact specifically
with the GST-Alx3 fusion protein, but not with control GST-Alx3ΔN140C, which lacks
the amino terminal region and the homeodomain, or with GST-C/EBPβ. Truncated
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versions of [35S]-Met-labeled Alx3 generated by deletion of residues spanning either
the carboxy- or the amino-termini of Alx3, but leaving intact the homeodomain, did not
affect dimerization with the GST-Alx3 fusion protein (Fig. 4D). Dimerization was also
observed using labeled Alx3143-228 (Fig. 4E), but not labeled Alx3175-343, which lacks
part of the homeodomain (not shown). In addition none of the labeled versions of Alx3
was observed to bind to control GST or to GST-Alx3ΔN140C. Finally, we observed that
Alx3143-228 can dimerize with GST-Alx3143-228 (Fig. 4E). Thus, these experiments
indicate that the segment of Alx3 corresponding to the homeodomain is necessary and
sufficient for homodimerization, and that the presence of DNA corresponding to a
cognate P3-like site is not required for Alx3 homodimer formation.
Alx3 binds selectively to specific TAAT-containing DNA sites–A number of studies have
characterized the binding properties of paired- and aristaless-like homeoproteins to P3
and related DNA elements (13,17,22,29,31). However, it is important to bear in mind
that P3-like elements appear not to be common in nature and that target genes regulated
by Alx3 and related transcription factors are unknown. To investigate whether Alx3 can
regulate transcription in the absence of P3-dependent dimerization, we took advantage
of the circumstance that Alx3-expressing RC2.E10 cells also express the genes
encoding the neuropeptide hormone somatostatin and the glial fibrillary acidic protein
(GFAP) (18,19), both of which are regulated by promoters that operate in a cell-specific
manner (18,32,33).
The promoter region of the somatostatin gene contains at least four
homeodomain-binding DNA cis-regulatory elements with TAAT core motifs, known as
SMS-UE-B, SMS-TAAT1, SMS-TAAT2 and SMS-TAAT3, the function of which has
been studied in detail in pancreatic and neural cells (18,33-35). In the case of the GFAP
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gene, studies on the regulation of its expression by homeodomain proteins have not
been reported. However, inspection of the sequence of the rat GFAP gene promoter
revealed the presence of three different sites containing a TAAT motif. We named them
GFAPT1, GFAPT2 and GFAPT3, respectively. GFAPT1 is located approximately 1485
base-pairs upstream from the transcription start site defined by Condorelli et al. (36),
and GFAPT2 and GFAPT3 are located about 796 and 450 nucleotides from the
transcription initiation site, respectively.
As none of these somatostatin and GFAP elements resemble P3 or P5 sequences,
we first used EMSA to test whether Alx3 can indiscriminately bind to all of them or
whether its binding is specific only for some selected TAAT-containing sequences.
Incubation of recombinant Alx3 with 32P-labeled synthetic oligonucleotides
corresponding to each one of the above mentioned somatostatin or GFAP sites indicated
that Alx3 can only bind to SMS-TAAT2 and GFAPT3, but not to any of the other
TAAT probes (Fig. 5A). Deletions of N- or C-terminal segments of Alx3 did not alter
binding to these sites, and, similar to what we found using the P3 and P5
oligonucleotides, we determined that the region of Alx3 corresponding to the
homeodomain and adjacent amino acids (Alx3143-228) is sufficient for binding to SMS-
TAAT2 (Fig. 5B) and to GFAPT3 (not shown). In addition, we confirmed that Alx3
binds to SMS-TAAT2 and GFAPT3 as a monomer by mixing Alx3143-228 with other
truncated versions of Alx3 in the binding reaction. Contrary to what was observed in the
case of the P3 oligonucleotide, this did not result in the formation of additional
intermediate bands corresponding to dimeric complexes (Fig. 5C).
Nuclear proteins alter the DNA binding specificity of Alx3.–To verify whether
endogenous Alx3 is able to bind selectively to these elements in the same sequence-
specific manner, we carried out EMSA using nuclear extracts of RC2.E10 cells in the
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presence of a specific anti-Alx3 antiserum. For comparison, we also used nuclear
extracts of pancreatic islet-derived somatostatin producing RIN-1027-B2 cells. We have
previously shown that nuclear proteins from both RC2.E10 and RIN-1027-B2 cells bind
to somatostatin TAAT-containing elements forming several sequence-specific protein-
DNA complexes (18,33,35). Expression of Alx3 in RC2.E10 and RIN-1027-B2 cells
was confirmed by western blot (Fig 6A).
In the experiments reported above, we found that recombinant Alx3 does not
bind SMS-UE-B. Surprisingly, however, we found that addition of the Alx3 antiserum
to RC2.E10 nuclear extracts incubated with 32P-labeled SMS-UE-B results in the
disappearance of one of the protein-DNA complexes detected, indicating that in the
presence of other nuclear proteins Alx3 does recognize SMS-UE-B, and that the
antibodies prevent binding of Alx3 to this element (Fig. 6B). Previously, we described
that IDX1, a different homeodomain protein present in neural cells binds the SMS-UE-
B element (35). Interestingly, we found that the addition of two different anti-IDX1
antisera to the binding reaction resulted in the disappearance of the same band that
disappears with the anti-Alx3 antiserum, suggesting that the protein complex bound to
SMS-UE-B may contain both homeoproteins (Fig. 6B).
Incubation of RC2.E10 nuclear extracts with 32P-labeled probes corresponding
to SMS-TAAT1, SMS-TAAT2 or SMS-TAAT3 in the presence of anti-Alx3
antiserum resulted in no perturbations of any of the bands observed, confirming that
Alx3 does not bind to SMS-TAAT1 (Fig. 6B) and SMS-TAAT3 (not shown), and
suggesting that in the presence of other nuclear proteins Alx3 does not recognize
SMS-TAAT2 (Fig. 6B). This situation is similar to that reported for IDX1, that
recognizes SMS-TAAT2 in somatostatin-producing pancreatic cells, but not in
somatostatin-producing neural cells, despite the fact that it is expressed in both cell
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types (34,35). This prompted us to investigate whether Alx3 present in pancreatic
cells binds SMS-TAAT1 or SMS-TAAT2. We found that the addition of anti-Alx3
antiserum when the binding reaction is carried out with RIN-1027-B2 nuclear extracts
causes the disappearance of the upper bands detected with both probes (Fig. 6B).
Another DNA-protein complex with a faster electrophoretic mobility was affected by
the addition of the anti-Alx3 antiserum in the case of the SMS-TAAT1 probe, but not
in the case of the SMS-TAAT2 probe (Fig 6B). In addition, using α251 and α253,
two different anti-IDX1 antisera that recognize either the N- or the C-terminal
residues of the protein, respectively (37,38), we confirmed IDX1 binding to SMS-
TAAT1 and SMS-TAAT2 in nuclear extracts of RIN-1027-B2 cells, but not in
nuclear extracts of RC2.E10 cells (Fig. 6B). Interestingly, the lower band affected by
the IDX1 antisera in the case of the SMS-TAAT1 probe coincides with one of the
bands affected by the Alx3 antiserum, suggesting that both proteins may interact as
part of the same complex bound to SMS-TAAT1 in pancreatic cells.
To gain information about the binding of Alx3 to native chromatin in vivo, we
used a ChIP assay to address whether this transcription factor binds to its cognate
elements on the somatostatin promoter in the context of the endogenous gene. We
found that the anti-Alx3 antiserum, but not control serum, immunoprecipitates a
fragment of formaldehyde cross-linked chromatin from RIN-1027-B2 cells that
contains the SMS-TAAT elements (Fig. 6D). Therefore, it is possible that the
somatostatin gene is a target for regulation by Alx3 in these cells.
In the case of the EMSA carried out with the TAAT-containing sites of the
GFAP gene, we observed that incubation of RC2.E10 nuclear extracts with each one of
the corresponding probes resulted in the generation of several DNA-protein complexes.
Competition with homologous and heterologous oligonucleotides demonstrated that
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binding is sequence-specific (data not shown). Addition of anti-Alx3 or anti-IDX1
antisera did not alter the banding pattern observed with GFAPT1 or GFAPT2 (Fig. 6C).
However, when GFAPT3 was used, addition of antisera against Alx3 resulted in the
disappearance of the slowest migrating band, an effect that was not observed with
control normal rabbit serum or with a IDX1-specific antisera (Fig. 6C). Thus, in the
presence of nuclear proteins, Alx3 shows a pattern of sequence-specific binding to
TAAT-containing GFAP promoter sites similar to the one observed with recombinant
Alx3.
Alx3 activates transcription from somatostatin TAAT-containing elements in a cell-
specific manner.–To determine whether Alx3 binding to somatostatin TAAT-containing
DNA sites correlates with transcriptional activity, we carried out transient transfection
experiments using RC2.E10 and RIN-1027-B2 cells. For this purpose, we used reporter
plasmids constructed by placing the SMS-UE-B, SMS-TAAT1 or SMS-TAAT2
elements at position –65 of the somatostatin promoter in the plasmid SMS65-CAT,
which contains the smallest 5’ deletion fragment of the rat somatostatin promoter that
retains activity in both RIN-1027-B2 and RC2.E10 cells (18,33). Cotransfection of the
Alx3 expression plasmid with these reporter plasmids in neural RC2.E10 cells did not
result in a significant increase in CAT activity (Fig. 7A). In pancreatic RIN-1027-B2
cells, Alx3 did not increase the activity elicited by UE-B-SMS65, but produced a 2-3
fold increase in the activity elicited by TAAT1-SMS65 or TAAT2-SMS65 (Fig. 7A).
In addition to neural and pancreatic cells that express endogenous Alx3, we
tested two other heterologous cell lines. In Hela cells, Alx3 stimulated the activity of
UE-B-SMS65 by approximately 2-fold, but induced a robust enhancement of the
activity elicited by TAAT1-SMS65 or TAAT2-SMS65 (Fig. 7A). In contrast, Alx3 did
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not enhance the CAT activity elicited by any of these reporters when cotransfected in
BHK-21 cells (Fig. 7A).
It is generally accepted that transcriptional transactivation by aristaless-like
homeoproteins requires their binding to DNA in the form of cooperative dimers (17,29).
However, our data generated by EMSA indicate that Alx3 does not bind to somatostatin
TAAT-containing elements as a homodimer. Since IDX1 binds to these elements in
RIN-1027-B2 cells and interactions between different types of homeodomain
transcription factors are not uncommon, we tested whether Alx3 and IDX1 may
cooperate to activate transcription from these sites. We found that cotransfection of
Alx3 and IDX1 expression vectors with the SMS-UE-B reporter plasmid in pancreatic
RIN-1027-B2 cells did not result in an increase in CAT activity (Fig. 7B). Also, the
increase in transcriptional activity elicited by Alx3 on the SMS-TAAT1 and SMS-
TAAT2 reporters was not enhanced in the presence of IDX1, which in fact caused a
decrease in Alx3-induced CAT activity in the case of SMS-TAAT2 (Fig. 7B).
Additional experiments indicated that IDX1 does not enhance Alx3-dependent
transcriptional activity elicited from somatostatin reporters cotransfected in Hela or
BHK-21 cells. These experiments indicate that there are no functional interactions
between Alx3 and IDX1 to transactivate somatostatin gene regulatory elements in the
cell lines tested.
Discussion
Proline-rich domains confer transcriptional transactivation functions to Alx3.–In the
present study, we show that three different proline-rich domains present in Alx3
contribute in different degrees to activate transcription from a P3 site. Deletion of the
entire proline-rich domain Pro1 reduced Alx3 activity by more than half. Thus, the
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remaining activity must be contributed by Pro2 and Pro3 domains, because the
homeodomain itself (Alx3143-228) lacks the capacity to activate transcription. A further
deletion of the Pro2 domain resulted in a truncated Alx3 protein that does not exhibit
transactivation activity, indicating that the Pro3 domain is unable to function on its own.
However, the Pro3 domain does contribute to the overall transcriptional activity of the
protein, because when deleted from the full length Alx3 the magnitude of the
transcriptional response elicited by the resulting C-terminal truncated protein is reduced
by approximately 50%. Thus, the Pro1 and Pro2 proline-rich domains are necessary, but
not entirely sufficient, for function of Alx3, and require the cooperation of the Pro3
domain to display full transcriptional activity.
The reduced transcriptional activity of the truncated versions of Alx3 are not
likely due to changes in their ability to bind DNA, because even the smallest fragment
used (Alx3143-228) contains two nuclear localization signals similar to those characterized
in the related homeoprotein Cart1 (31) and binds the P3 site efficiently. Rather, it is
possible that proline-rich domains provide a three dimensional docking structure for
transcriptional coupling proteins or coactivators (9,19,32) which would not be recruited
by truncated Alx3 due to absence of an interacting surface, as it is known that proline
residues are critical for many types of protein-protein interactions (39). However, it is
also possible that the function of proline-rich residues is linked to local changes in
protein structure (40) so that absence of a specific segment of the protein would alter the
conformation of an interacting surface located at a distance (41,42).
The relatively high proline content of Alx3 may also explain the discrepancy
between its predicted molecular mass (36.9 kDa) and the apparent molecular mass
indicated by its electrophoretic migration (see figures 4C and 6A), because it is known
that proline-rich proteins migrate anomalously on SDS-polyacrylamide gels (43). The
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difference between the predicted and the observed molecular mass is smaller in the case
of the related transcription factor Alx4, which contains a significantly lower number of
proline residues (9,14,44).
Functional domains outside the homeodomains of Alx4 and Cart1, the most
closely related transcription factors to Alx3, have not been characterized, but significant
differences with Alx3 are apparent. Cart1 does not contain regions enriched in proline
residues, and the distribution and proportion of proline residues in Alx4 are different
from those of Alx3. Thus, even though these proteins exhibit redundant or overlapping
functions, the transcriptional mechanisms by which they act may be different.
In Cart1 and in Prx proteins the aristaless domain has an inhibitory function
(45). This does not seem to be the case for Alx3, because deletion of the region that
contains the aristaless domain (Alx31-279) does not result in transcriptional enhancement
in transfected cells, consistent with the notion that Alx3 contains a divergent aristaless
domain that appears not to be functional (46).
Alx3 binds cooperatively to a generic P3-like site.–Alx3, Alx4 and Cart1 belong to the
so called Q50 subgroup of the paired class homeodomain proteins characterized by the
presence of a glutamine residue at position 50 of the homeodomain (8). Proteins of this
group bind preferentially to P3 sites as dimers in a cooperative manner, whereas binding
to P5 sites occurs in monomeric form (22,47), a situation that has been confirmed for
Alx4 and Cart1 (13,17,29,31). Alx3 has not been studied so extensively, but recently
Brouwer et al. (46) showed that binding of Alx3 to P3 is inhibited by the aristaless
domain of Cart1, suggesting that sequences located outside the homeodomain can affect
binding of aristaless-related proteins to their target DNA sites. Consistent with previous
work on paired Q50 homeoproteins (22,29), our study shows that a segment of Alx3
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spanning the homeodomain (Alx3143-228) contains sufficient structural information for
binding to P3 and P5 sites, and that monomeric binding to P5 is not sufficient for
functional activity.
Selective cell-specific binding of Alx3 to different TAAT-containing sites.–P3-like sites
are not commonly found in the promoters of mammalian genes, and only a small
number of natural P3-like binding sites present in Drosophila genes have been studied
(30,48). This difficulty has precluded identification of target genes regulated by Alx3
and related transcription factors. We took advantage of the coexpression of Alx3 with
somatostatin in neural RC2.E10 cells (which also express GFAP) and in pancreatic
RIN-1027-B2 cells to explore the binding preferences of Alx3 in two different types of
nuclear protein environments and to compare them to those exhibited by recombinant
Alx3 in isolation. Coexpression of Alx3 with somatostatin and GFAP in RIN-1027-B2
and RC2.E10 cells does not necessarily imply that these genes are regulated by Alx3 in
vivo, but this possibility can not be formally excluded because our ChIP experiments
show that Alx3 occupies the promoter of the somatostatin gene, and it is expressed in
neural and pancreatic islet cells of embryonic and adult rats (our unpublished
observations).
We found that, of a total of seven TAAT-containing sites present in the promoter
regions of the somatostatin and GFAP genes, recombinant Alx3 only binds to the
GFAPT3 and SMS-TAAT2 elements, which contain the core sequence motifs
TAATTG and TAATTA, respectively. None of these two motifs is present in any of the
other somatostatin or GFAP oligonucleotides tested. The TAATTG motif contained in
GFAPT3 is also present in the P3 and P5 sites used in this study and fits the consensus
half site preferred by paired Q50 homeodomain proteins (22). Transcriptional activity of
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aristaless-like proteins bound to this motif requires cooperative dimerization on the
DNA, which is made possible by the existence of a palindromic TAAT motif in P3
sites. Therefore, GFAPT3 resembles a P5-like site in the sense that binding of an Alx3
monomer is not capable of eliciting transcriptional transactivation, as we observed in
our transfection experiments using GFAP-based luciferase reporters (not shown).
The TAATTA motif present in SMS-TAAT2 corresponds to a preferred
consensus binding site for paired transcription factors with a histidine (H50) or
isoleucine (I50) residue at position 50 of the homeodomain (47). Interestingly, we found
that recombinant Alx3 and Alx3 present in pancreatic RIN-1027-B2 binds to SMS-
TAAT2, but Alx3 present in nuclear extracts of neural RC2.E10 cells was prevented
from binding to this site. Although the presence of competing nuclear proteins that
recognize the same site can not be excluded  (49), a more likely possibility is that Alx3
associates with other cell-specific proteins to form complexes with different sequence
specificities in neural cells.
The TAATGG motif of the SMS-UE-B oligonucleotide is a preferred consensus
binding site for Fushi tarazu (47), which is not a paired-like homeoprotein but contains
a glutamine at position 50 within its homeodomain. Paired Q50 homeoproteins
including Alx4 can also bind to a TAATGG half site (22), and therefore it is not entirely
surprising that although recombinant Alx3 does not recognize the SMS-UE-B, Alx3
expressed in RC2.E10 cells binds this site, perhaps favored by neural Alx3 interacting
proteins. An analogous situation may explain the occupation of the SMS-TAAT1 site by
Alx3 present in nuclear extracts of RIN-1027-B2 cells, even though recombinant Alx3
does not recognize this site.
Thus, recombinant Alx3 used in isolation from other nuclear proteins selectively
recognizes different versions of TAAT sites that differ on their flanking nucleotides. In
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turn, this binding selectivity can be altered in the presence of different nuclear protein
environments. These data support the notion that Alx3 shows structural plasticity for the
recognition of distinct target sites that is modulated in a cell-specific manner via
interactions with other nuclear proteins.
Alx3 transactivates transcription from target DNA regulatory elements in a cell-specific
manner.–Transfections in different cell lines confirmed the notion that nuclear protein
environment may modulate binding and transcriptional activity of Alx3 from selected
somatostatin regulatory elements in a cell-specific manner. Thus, in neural RC2.E10
cells Alx3 is unable to transactivate from any of the somatostatin regulatory elements
tested, despite the fact that it was found by EMSA to occupy at least the SMS-UE-B site
in nuclear extracts prepared from these cells. In pancreatic RIN-1027-B2 cells Alx3 was
found to increase transcription from the SMS-TAAT2 site, consistent with the binding
data obtained with recombinant and nuclear Alx3, and from SMS-TAAT1 site,
consistent with the observed cell-specific occupation of this site detected with nuclear
extracts. Finally, in two heterologous cell lines, opposite effects were observed. On the
one hand, in Hela cells Alx3 was shown to transactivate from all the somatostatin
reporters tested, but in BHK-21 cells, on the other hand, it was unable to transactivate
from any of them.
It is generally accepted that aristaless-related homeoproteins are unable to
activate transcription acting in monomeric form. Thus, transactivation from SMS-
TAAT2 and SMS-TAAT1, where Alx3 binds as a monomer, may require the interaction
with other homeodomain or non-homeodomain proteins bound in its vicinity. Three
dimensional studies show that a TAATTAAT motif similar to the one in SMS-TAAT2
could accommodate the binding of two homeodomain proteins located at opposite sides
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of the DNA helix (50,51). As for non-homeodomain related transcription factors, Alx3
can interact with basic-helix-loop-helix proteins (M.M. and M.V., unpublished
observations), and Alx4 has been shown to establish functional interactions with LEF-1
to regulate the activity of the N-CAM promoter (52). Further studies are required to
identify functionally active Alx3-interacting proteins.
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Footnotes
1Abbreviations: CAT, chloramphenicol acetyltransferase; ChIP, chromatin
immunoprecipitation; GST, glutathione S-transferase; EMSA, electrophoretic mobility
shift assay; GFAP, glial fibrillary acidic protein.
2The nucleotide sequence for the rat Alx3 cDNA has been deposited in the GenBank
database under GenBank Accesion Number AY488087.
Functional characterization of Alx3
33
FIGURE LEGENDS
Figure 1. Northern blot analysis of RNA extracted from the head or trunk of rat E12
embryos. The same blot was hybridized with a rat Alx3 probe (top), stripped after
exposure, and rehybridized with a rat actin probe (bottom).
Figure 2. Diagrammatic depiction of the structure of rat Alx3. Numbers on the top
indicate the position of residues delimitating different domains. The three proline-rich
domains (Pro1, Pro2 and Pro3) are indicated as striped boxes, and the homeodomain
(HD) as a black box. Percentages of amino acid identities found in Alx3 orthologs from
mouse, hamster and human are indicated below. The amino acid sequence of the
homeodomain is identical for all these species.
Figure 3. A) Relative luciferase activities elicited in BHK-21 cells cotransfected with
either P3- or P5-luciferase reporter plasmids (3xP3-Luc and 3xP5-Luc, respectively, 5
µg of each) and increasing amounts of control pcDNA3 or pcDNA3-Alx3 (Alx3) as
indicated. B) Schematic depiction of the truncated versions of Alx3 used in the
transfection experiments reported in panel C. Proline-rich domains (Pro1, Pro2 and
Pro3) are indicated as striped boxes, and the homeodomain (HD) as a black box. C)
BHK-21 cells were cotransfected with 3xP3TK-Luc (5 µg) and pcDNA3 encoding the
different truncated versions of Alx3 (1 µg) indicated schematically shown in panel B.
D) Western immunoblot of nuclear extracts of transfected cells confirming the
expression of truncated versions of Alx3. The Alx3 homeodomain (Alx3143-228) was run
on a different gel (20% polyacrylamide) due to its relative small size (not shown).
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Values for luciferase activities represent the mean + s.e.m. of at least three independent
experiments carried out in duplicate.
Figure 4. A) Electrophoretic mobility shift assays showing cooperative and non
cooperative binding of Alx3 to P3 and P5 sites, respectively. The same amounts of
reticulocyte lysates (0.3-3 µ l) containing Alx3143 were incubated with probes
corresponding to P3 and P5 sites. Note the formation of Alx3 dimers (Di) on the P3
probe at concentrations that only yield monomers (Mo) on the P5 probe. B)
Demonstration of dimer formation on a P3 probe by the generation of Alx3143/Alx3143-228
complexes. Both Alx3143 and Alx3143-228 shift the P3 probe to a higher position (Alx3143-
Di and Alx3143-228-Di, dimers) than they shift the P5 probe (Alx3143–Mo and Alx3143-
228–Mo, monomers). When the two polypeptides are mixed together, an intermediary
band appears (Alx3143/Alx3143-228) representing a dimer of Alx3143 and Alx3143-228. Note
the absence of dimers on the P5 probe, even though higher amounts of Alx3 were
present in these binding reactions. Control, unprogrammed reticulocyte lysate. C) GST
pull-down assay showing Alx3 homodimerization in the absence of a P3-like element.
35S-labeled in vitro translated full length Alx3 was incubated with the indicated purified
glutathion-S-transferase (GST) fusion proteins expressed in bacteria and bound to
glutathion sepharose beads. Alx3 interacts with GST-Alx3 (lane 1), but not with GST-
C/EBPβ (lane 2), or with control GST-Alx3ΔN140C (lane 3). D) Purified GST-Alx3
was incubated with truncated versions of 35S-labeled, in vitro translated Alx3. Full
length Alx3 (Alx3FL), N-terminal deletions to amino acids 57 (Alx357), 91 (Alx391) or
143 (Alx3143), or C-terminal deletions from amino acids 228 (Alx31-228) or 279 (Alx31-
279) were used. Labeled products did not bind to GST or to GST-Alx3ΔN140C (not
shown). E) Binding of 35S-labeled, in vitro translated Alx3143-228 to GST-Alx3143-228 and
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GST-Alx3FL, but not to GST or to GST-Alx3ΔN140C. In this case, the labeled Alx3143-
228 polypeptide was resolved in a 20% polyacrilamide gel.
Figure 5. A) Electrophoretic mobility shit assays showing selective binding of
recombinant Alx3 to oligonucleotides corresponding to TAAT-containing sites present
in the somatostatin or GFAP promoters. Oligonucleotide probes used in each reaction
are indicated at the top. Binding reactions were carried out in the absence or presence
(+) of competing oligonucleotides of identical probe sequence (wild type, WT comp) or
in the presence of the corresponding TAAT mutated oligonucleotide (Mut comp), used
in a 100-fold molar excess. B) Binding of reticulocyte lysate (RL)-synthesized full
length or truncated Alx3 to a SMS-TAAT2 probe. Left side (lanes 2-5), binding
reactions with full length Alx3 were carried out in the absence (-) or presence of
competing oligonucleotides (50- or 100-fold molar excess) of identical probe sequence
or in the presence of a non-specific competitor (NSC) with the TAAT motif mutated,
used in a 100-fold molar excess. Right side (lanes 6-12) shows binding of amino and
carboxy terminal truncated versions of Alx3. Note that a fragment corresponding to the
homeodomain and adjacent residues (Alx3143-228) is sufficient for binding to the SMS-
TAAT2 probe. C) Alx3 binds to SMS-TAAT2 as a monomer. Truncated versions of
Alx3 synthesized in vitro only generate one single complex bound to SMS-TAAT2
(compare with the situation observed on a P3 site, shown in Fig. 4). Mixture of each
Alx3 fragment with a polypeptide corresponding to the homeodomain and adjacent
residues (Alx3143-228) does not result in the formation of intermediate DNA-protein
complexes. In B and C the probe has been run off the gel to increase the separation of
the complexes.
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Figure 6. A) Western immunoblot showing the presence of Alx3 in nuclear extracts
prepared from embryonic cortex-derived RC2.E10 cells and from pancreatic islet-
derived RIN-1027-B2 cells, but not in extracts prepared from BHK-21 fibroblasts. B)
Electrophoretic mobility shift assay showing that Alx3 and the homeoprotein IDX1
present in nuclear extracts of neural RC2.E10 cells bind to the somatostatin SMS-UE-B
element (left) but not to the SMS-TAAT1 or SMS-TAAT2 elements. However, Alx3
and IDX1 present in nuclear extracts of pancreatic RIN-1027-B2 bind to SMS-TAAT1
and SMS-TAAT2. Arrows indicate the complexes disrupted by the anti-Alx3 and anti-
IDX1 antisera. C) Alx3 present in nuclear extracts of neural RC2.E10 cells binds
selectively to the GFAPT3 element (right), but not to the GFAPT1 (left) or GFAPT2
(center) elements. Arrow indicates the band disrupted by the anti-Alx3 antiserum. Note
that IDX1 did not bind any of the GFAP TAAT-containing elements. Control normal
rabbit serum (NRS), an antiserum against Alx3, or one of two antisera to IDX1 (251 or
253), were added to the binding reactions shown in B and C, 15 minutes before the
addition of the probes. D) Chromatin immunoprecipitation assay carried out in the
presence of anti-Alx3 antiserum or normal rabbit serum (NRS). Shown are PCR
products corresponding to the region of the somatostatin gene promoter that contains
the SMS-TAAT sites recognized by Alx3.
Figure 7. A) Relative CAT activities elicited by expression vector pcDNA3-Alx3 (2
µg) cotransfected with the indicated somatostatin TAAT-containing reporter plasmids
(5 µg) in four different cell lines (RIN-B2 denotes pancreatic RIN-1027-B2 cells).
Values are expressed as fold induction relative to controls in which each reporter was
cotransfected with empty pcDNA3, and represent the mean + s.e.m. of at least three
independent experiments. B) Relative CAT activities elicited by each somatostatin
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reporter plasmid in the absence (-) or presence of pcDNA3-Alx3 and/or pcDNA3-IDX1
observed after cotransfections in pancreatic RIN-1027-B2 cells. Values are expressed as
percentages of the activities elicited by a control CMV-CAT reporter transfected in
parallel and represent the mean + s.e.m. of at least three independent experiments.







